Illumina, Inc. today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a pre-commercial company founded to accelerate early screening of cancer.

The Precede consortium and Konica Minolta Precision Medicine said Tuesday that KMPM and its subsidiaries, Ambry Genetics and Invicro, have partnered with the international effort to advance diagnostic and screening approaches for pancreatic cancer early detection.

Tempus said on Tuesday that it has submitted a premarket approval application for its next-generation sequencing-based xT-Onco tumor profiling assay to the US Food and Drug Administration.

Clarified Precision Medicine on Friday said that it has completed its acquisition of molecular diagnostics firm Interpares Biomedicine.

Biocept reported after the close of the market on Monday that its second quarter revenues increased dramatically year over year, as the cancer diagnostics firm continued its provision of COVID-19 testing.

Tesis Labs and Personal Genome Diagnostics said Tuesday that they are collaborating to develop new genomic tests for cancer patients that combine somatic and germline variant results, with the goal of advancing market access and accelerating adoption of their products.

NEW YORK – Qiagen said on Thursday that it has formed a global strategic alliance with Japan's Sysmex to develop and commercialize cancer companion diagnostics using Sysmex's Plasma-Safe-SeqS next-generation sequencing technology.

On December 19, at the 16th International Respiratory Symposium in Changshu, Abbott announced that it had joined the International Smart Health Alliance and signed an important strategic cooperation with the China Lung Cancer Prevention Alli

Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production.

NGS cancer companion diagnostics is an emerging industry in China, and its industry concentration has gradually increased over the past 6 years around development.